Pharma company to relocate to Houston following CPRIT grant
Salt Lake City-based Salarius Pharmaceuticals LLC will relocate to Houston following an $18.69 million grant from the Cancer Prevention and Research Institute of Texas.
CPRIT awarded Salarius and Pelican Therapeutics two grants totaling nearly $34 million to recruit both of the companies to the Lone Star State. Pelican will be located in Austin, according to a statement.
Salarius is developing a drug that will target Ewings Sarcoma, a pediatric bone cancer with no targeted therapies. Currently…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Joe Martin Source Type: news
More News: Biotechnology | Bone Cancers | Cancer | Cancer & Oncology | Ewing's Sarcoma | Grants | Health | Health Management | Pediatrics | Pharmaceuticals | Sarcomas